Top Markets
Coin of the day
Predictive Technology Group, Inc. Predictive Technology Group, Inc.

Predictive Technology Group, Inc.

PRED
株式のランク #41305
Predictive Technology Group, Inc. (PRED), along with its affiliated companies,... Predictive Technology Group, Inc. (PRED), along with its affiliated companies, specializes in the creation and market introduction of cutting-edge molecular diagnostic and therapeutic solutions, as well as human cellular and tissue-based products (HCT/Ps). The company's operations are divided into two primary segments: Human Cellular and Tissue Products (HCT/Ps), and Diagnostics and Therapeutics. PRED offers genetic testing services like FertilityDX, which assists couples experiencing infertility, and ARTguide, a genetic test for women struggling with infertility often linked to endometriosis and other genetic conditions. In the realm of regenerative medicine, its product offerings include AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte. Furthermore, Predictive Technology Group has a cooperative arrangement with Atrin Pharmaceuticals LLC to advance molecular diagnostic tools, which are intended to refine the selection of patients for cancer treatments. Founded in 2005, the company initially operated under the name Global Enterprises Group, Inc., before rebranding to Predictive Technology Group, Inc. in July 2015. Its corporate headquarters are situated in Salt Lake City, Utah.
株価
$0.0001
最終同期: 2024-12-31
時価総額
$28.10K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Predictive Technology Group, Inc. (PRED)

カテゴリー

Predictive Technology Group, Inc.(PRED)の配当利回りの履歴
Predictive Technology Group, Inc.(銘柄コード: PRED)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Predictive Technology Group, Inc.(PRED)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)